Track 7 : Patient organizations and their role in drug development or clinical research

Rare disease drug development could benefit substantially from increased patient engagement and input to enhance understanding of the key aspects of disease impact, ways to measure these impacts and patients' perspectives on the benefit-risk profile of potential therapies.

 

    Related Conference of Track 7 : Patient organizations and their role in drug development or clinical research

    May 18-19, 2026

    15th World Congress on Rare Diseases and Orphan Drugs

    Prague, Czech Republic

    Track 7 : Patient organizations and their role in drug development or clinical research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in